The precise number of people affected by venous thromboembolism (VTE), that is either<unk>  vein<unk>  (DVT), pulmonary embolism (PE), or both, is unknown, but estimates range from 300,000 to 600,000 (1 to 2 per 1,000, and in those over 80 years of age, as high as 1 in 100) each year in the United States.  Estimates suggest that 60,000-100,000 Americans die of VTE, 10 to 30% of which will die within one month of diagnosis.  Among people who have had a DVT, one-half will have long-term complications (post-thrombotic syndrome) such as swelling, pain, discoloration, and scaling in the affected limb.  One-third (about 33%) of people with VTE will have a recurrence within 10 years.  Approximately 5 to 8% of the U.S. population has one of several genetic risk factors, also known as inherited thrombophilias in which a genetic defect can be identified that increases the risk for<unk> .
Deep vein thrombosis epidemiology and demographics
Varicose veins epidemiology and demographics
Portal vein thrombosis epidemiology and demographics
Atherosclerosis epidemiology and demographics
Thrombophilia epidemiology and demographics
Peripheral arterial disease epidemiology and demographics
Deep vein thrombosis classification scheme
Von Willebrand disease epidemiology and demographics